Sign in Subscribe
Cancer

Artificial Intelligence Revolutionizes Medical Imaging in Cardio-Oncology

Strategic Insights

— 1 min read

A groundbreaking study from University College Dublin has unveiled the enormous potential of Artificial Intelligence (AI) in transforming medical imaging for patients with cancer. According to the research, AI can significantly enhance the accuracy and efficiency of cardiotoxicity assessments in patients undergoing cancer therapy. The systematic review, which analyzed seven studies conducted between 2018 and 2023, found that AI can predict cardiotoxicity with high accuracy and improve imaging modalities for better patient outcomes.

Key Takeaways:

  • The study, published in the Journal of Engineering, highlights the potential of AI to revolutionize medical imaging in cardio-oncology, with the ability to predict cardiotoxicity in patients undergoing cancer therapy.
  • The research involved a systematic review of seven studies, including patients with breast cancer, conducted between 2018 and 2023, with most studies taking place in the United States (71%).
  • The studies used magnetic resonance imaging (MRI) as the primary imaging modality (57%), with the remaining studies using echocardiography.
  • The quality assessment of the studies showed an average compliance rate of 86% in all sections, indicating the robustness of the findings.
  • The research suggests that AI can enhance the accuracy and efficiency of cardiotoxicity assessments, paving the way for improved patient outcomes in cancer survivors at risk of cardiotoxicity.
  • The study's authors propose further research through larger, multicenter trials to validate AI applications and refine AI technologies for routine use.

Statistics:

  • 7 studies were included in the systematic review, conducted between 2018 and 2023.
  • 71% of the studies were conducted in the United States.
  • 86% of patients included in the studies had breast cancer.
  • 57% of the studies used magnetic resonance imaging (MRI) as the primary imaging modality.
  • The quality assessment of the studies showed an average compliance rate of 86% in all sections.
  • The number of patients included in the studies was not specified.

Sources:

  • NewsRx. University College Dublin Reports Findings in Artificial Intelligence (Application of Artificial Intelligence in Cardio-Oncology Imaging for Cancer Therapy-Related Cardiovascular Toxicity: Systematic Review). Journal of Engineering. May 26, 2025; p 3373.
  • Application of Artificial Intelligence in Cardio-Oncology Imaging for Cancer Therapy-Related Cardiovascular Toxicity: Systematic Review. JMIR Cancer, 2025;11.

Read more